688189.SHG Hunan Nucien Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
6.11 CNY
Close of Nov 5, 2026
5.47 11.39
Market cap
CNY 1.67B
P/E
-
P/B
2.09x
ROE
-9.5%
Dividend yield
0.16%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688189.SHG undervalued?

Graham number

The Graham number of Hunan Nucien Pharmaceutical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hunan Nucien Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Hunan Nucien Pharmaceutical Co Ltd yet.

Hunan Nucien Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hunan Nucien Pharmaceutical Co Ltd

Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular,…

Full company profile